Navigation Links
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
Date:7/12/2012

LIVERMORE, Calif. Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools.

Lab officials are seeking industry partners to license and commercialize the SpinDx technology, which can determine a patient's white blood cell count, analyze important protein markers, and process up to 64 assays from a single sample, all in a matter of minutes.

"In a doctor's office, time is money," said Anup Singh, manager of Sandia's biotechnology and bioengineering department. "Patients have become accustomed to an initial visit, some tests, samples that are sent off to a far-away lab, a wait of a week or more for results, more tests and charges every step of the way. With SpinDx, you can see results before you even leave the office."

(Visit www.youtube.com/SandiaLabs to view HD video footage of the "SpinDx" medical diagnostic tool)

The technology advances in SpinDx have profound implications for patient care. Heart attacks, strokes, infections, certain cancers and other afflictions could be detected days or weeks sooner than they are today, with no new burdens placed on patients or their doctors, Singh said.

The SpinDx platform has several advantages:

  • Small sample size: Patients merely have to provide a pin-prick sample of blood.
  • Ease of use: The device uses a spinning disk, much like a CD player, to manipulate a sample. The disks contain commercially available reagents and antibodies specific to each protein marker.
  • Custom applications: Singh envisions a "plug and play" approach whereby the physician chooses among a "cardiac disk," "immune disk" and similar options.
  • Inexpensive technology: The disks the crux of the technology cost pennies to manufacture.
  • Quick response time: Results can be delivered to the physician's computer in 15 minutes.

"We envision medical personnel using SpinDx routinely," said Greg Sommer, the Sandia researcher who spearheaded development of the project. "Instead of standard blood panels and costly lab tests, a SpinDx disk would be processed right in the office while the medical office staff is gathering routine data like temperature and blood pressure."

The platform also has homeland security and food processing applications.

Singh recently led a National Institutes of Health grant (grant # 1U01AI075441) to adapt the lab-on-a-disk platform for toxin diagnostics.

The device could be the most accurate method available to detect the botulinum toxin, said Sommer. Caused by the bacteria Clostridium botulinum, the botulinum toxin is one of the most toxic substances knowna miniscule quantity can deliver a lethal dose. But despite scientific advances, laboratory mice remain the only reliable way to test for botulism.

"The mouse bioassay is primitive, but remains the gold standard due to its sensitivity," Sommer said. "Our SpinDx botulinum assay vastly outperformed the mouse bioassay in head-to-head tests, and requires absolutely no animal testing. Plus there are a lot of cost and speed advantages."

While botulism is quite rare only about 145 cases are reported in the United States each year, according to the Centers for Disease Control and Prevention the lethality of the toxin makes it an attractive candidate for bioterrorism. "A very small amount in the food system could harm a lot of people," said Sommer.

Sandia's goal, Sommer said, is to create a handheld, point-of-care device that can be used in the field by emergency responders.

SpinDx's ability to process many substances also makes the device relevant for food safety testing. About 15 percent of botulism cases are food-borne. In 2007, 14 people in seven states contracted botulism from chile sauce due to faulty manufacturing equipment at a food plant in Georgia.

The Sandia team made improvements to the assay that enabled it to handle thick, viscous food substances. Collaborators at the U.S. Department of Agriculture provided high-quality botulinum antibodies that bind with high affinity, enabling higher sensitivity.

"Food processing plants are looking for something that can be integrated into their assembly lines," said Sommer. "Our device will be suitable because it's fast, inexpensive and simple to operate."

The team is developing a deployable prototype to run the assays, with the goal of a fully integrated, automated device for field testing. "We've done most of our testing in a benchtop setting, where we spin the sample on the disk and then read it out on a microscope," Sommer explained. "The next step is to automate those processes and get the system into users' hands. SpinDx has a lot of potential for so many applications."


'/>"/>
Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
Source:Eurekalert  

Related biology news :

1. Miniature Sandia sensors may advance climate studies
2. Trial seeks improved lung-cancer screening by combining imaging and biomarkers
3. Researchers take hibiscus efforts to commercialization
4. A study confirms that long commercials evoke stronger emotions
5. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
6. F1000 Research partners with figshare to provide smart ways of accessing data
7. Royal Astronomical Society and Oxford University Press partnership announced
8. Grants add to Northwestern-Qatar partnership
9. New museum-university partnership ushers in new era of environmental science education
10. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
11. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... announced that Brent Saunders , Allergan,s CEO and ... a fireside chat session at the RBC Capital Markets ... p.m. ET at The New York Palace Hotel in ... will be webcast live and can be accessed on ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: